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Angioedema is a common presenting symptom
among allergy practices. Angioedema is caused by
increased vascular permeability in the subcuta-
neous tissue of the skin and respiratory and gas-
trointestinal tracts.1 Acute angioedema is most
often due to an immunoglobulin E (IgE)–mediated
response to an inciting allergen and is classified
as a type I hypersensitivity reaction.1 However,
there is a broad differential for angioedema, includ-
ing hereditary and acquired disorders. One rare
diagnosis that occurs in the pediatric population
and that allergists must be familiar with is
angioedema-like cutaneous findings due to pho-
tosensitivity caused by cutaneous porphyrias.2We
present a case report of a child with a swelling of
hands and feet that mimicked angioedema and
hepatomegaly, ultimately diagnosed as erythro-
poietic protoporphyria (EPP).
Case Presentation
A 4-year-old previously healthy African American
girl presented to the emergency department with
swelling of hands and feet. The patient had been
at the beach all day,playing in the water and sand.
After a few hours, she had begun to experience a
burning sensation in her hands and feet, with asso-
ciated swelling and redness of the skin. No hives,
blistering, swelling of lips or face, or respiratory
or gastrointestinal symptoms were noted. There
was no history of any insect bites or trauma. There
was no medication or unusual food ingestion
before this episode. The patient’s medical history
included two episodes of a similar nature at the age
of 2 years, which were noted to be associated
with spending the day at the beach. These episodes
resolved spontaneously after 2 days. The patient
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also had a history of hives with amoxicillin use as
an infant; otherwise, there was no history of recur-
rent urticaria. Family history was significant for
allergic rhinitis in the mother, asthma in her half-
brother, and atopic dermatitis in her half-sister.
There was no reported family history of recurrent
swelling of the skin, chronic hives, or childhood
or unexplained deaths.
Examination revealed a well-nourished well-
developed female in no apparent distress. Vital
signs were stable, without fever, tachypnea, or
tachycardia. Weight and height were both in the
25th percentile for her age. Of note, an examina-
tion of her extremities revealed erythema, edema,
and tenderness on palpation of the hands and feet.
Her skin was hyperkeratotic and hyperpigmented
on the dorsa of her hands. No excoriations, denuded
areas, petechiae, or purpura were noted. Exami-
nations for Darier’s and Nikolsky’s signs were
negative. There was no evidence of der-
matographism. On abdominal examination, the
patient was noted to have a palpable nontender liver
edge approximately 4 to 5 cm below the right
costal margin. Sclerae were anicteric, and no jaun-
dice was noted. No splenomegaly was noted.
Laboratory evaluation included a complete
blood count and assessments of serum electrolytes,
blood urea nitrogen, creatinine, and glucose, the
results of which were normal. Other tests that
were performed and their results are as follows:
erythrocyte sedimentation rate (ESR), 22 mm/h
(0–13 mm/h); alanine transaminase, 301 U/L
(30–65 U/L); aspartate transpeptidase (AST),
182 U/L (15–37 U/L); and g-glutamyltransferase,
444 U/L (5–55 U/L). Total protein, bilirubin, albu-
min, antinuclear antibody (ANA), C4, and the
viral hepatitis panel were within normal limits.
Abdominal ultrasonography revealed a mildly
enlarged liver of normal echogenicity and without
evidence of cholelithiasis.
During the hospital course,the patient received
intravenous morphine sulfate and oral diphenhy-
dramine (12.5 mg, as needed) for pain and itchi-
ness. The edema, erythema, and pain of the hands
and feet resolved within 48 hours, without any
scarring.
The allergy service was consulted to assist in
the evaluation of the cutaneous findings. The ini-
tial differential diagnosis included acute allergic
angioedema, hereditary or acquired angioedema
from C1 inhibitor deficiency, idiopathic
angioedema, contact dermatitis, viral or bacterial
infection with skin manifestations, autoimmune
inflammatory disorders, malignancy, and metabolic
disorders (including cutaneous porphyrias).1
The work-up included immediate-hypersensitiv-
ity skin testing with indoor and outdoor aeroal-
lergens to evaluate for an IgE-mediated trigger for
the pruritic dermatitis. This was performed with
the prick method,and the result was negative with
a positive histamine control. With a normal C4 level
during an acute episode, hereditary or acquired
angioedema from C1 inhibitor deficiency was
unlikely but was not fully ruled out. Autoimmune
disorders were less likely because the ANA level
was normal and the ESR was elevated only mildly,
but an assessment of extractable nuclear antigens
was not done. The normal complete blood count
lessened the likelihood that the skin findings were
from a viral or bacterial source or from a malig-
nancy such as leukemia. As the erythema and
edema were of acute onset and resolved within 48
hours, contact dermatitis was less likely to have
been the cause. The liver transaminases were per-
sistently elevated,and viral hepatitis testing results
were negative, which prompted further testing for
metabolic disorders, including urine and plasma
porphyrin analysis and liver biopsy. The patient did
have a significantly elevated protoporphyrin level
in the plasma (1,970 mg/mL [0.4–4.8 mg/mL]), and
examination of the liver biopsy specimen con-
firmed the diagnosis of EPP; there was an accu-
mulation of dark brown pigment displaying pathog-
nomonic Maltese-cross figures on birefringence,
with associated nodular fibrosis.3No genetic test-
ing has been performed to date.
The patient was started on beta carotene,
cholestyramine, ursodiol, vitamin E, and sun-
screen (sun protective factor [SPF] 50). The patient
has been on this treatment for the last 10 months,
and her liver function has been stabilized; however,
she has had intermittent episodes of erythema and
itchiness of the skin on sun-exposed areas such as
her face and extremities, even with sunscreen use.
The pruritus has been partially alleviated with the
administration of hydroxyzine. The patient’s father,
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who is asymptomatic, was subsequently found to
have elevated liver transaminases; however, he
has refused further evaluation through liver biopsy.
Discussion
EPP is a rare disorder of heme biosynthesis char-
acterized by early-childhood onset of acute pho-
tosensitivity of sun-exposed skin.4,5 It is an auto-
somal dominant disorder with incomplete
penetrance.6 Its prevalence in the general popu-
lation is 10 to 20 per 100,000, without any eth-
nic or gender predominance.3 EPP is caused by
a deficiency of ferrochelatase, the final enzyme
in heme synthesis, which leads to an accumula-
tion of protoporphyrin in various tissues, includ-
ing the skin and liver.5 The release of protopor-
phyrin from erythrocytes is increased if the
erythrocytes are exposed to light. The cutaneous
symptoms are a consequence of protoporphyrin-
sensitized photodamage of endothelial cells as
well as initiating inflammatory pathways. Free
oxygen radicals are released from the light-
excited protoporphyrins, which leads to peroxi-
dation of lipids and cross-linking of membrane
proteins, which causes hemolysis of erythro-
cytes.2 Protoporphyrin also induces the release of
mast-cell mediators such as histamine,
prostaglandin D, leukotrienes, and platelet-
activating factor.1 Complement activation with the
generation of anaphylatoxins also plays a role in
the phototoxicity.2 Polymorphonuclear cell
chemotaxis also increases to the affected area after
light exposure.2
Typically, EPP presents in childhood; the
affected child cries and complains of burning of
the skin on the face and hands within minutes
of sun exposure. Delayed effects that occur sev-
eral hours later include swelling or erythema of
the affected area.6 Petechiae and purpura may
also occur; however, blisters or vesicles are
uncommon. Patients may eventually develop a
waxy cobblestone-like induration of the affected
area, frequently on the knuckles and fingers.2
Major presenting symptoms and signs include
burning (97%), edema (94%), itching (88%),
erythema (69%), and scarring of the skin (19%).7
Patients with EPP can develop liver disease
ranging from stable liver transaminase elevation
to acute hepatic failure requiring liver trans-
plantation. Less than 10% of patients with EPP
will develop severe liver disease.3 Hyperpig-
mented cholelithiasis from hemolysis also may
present in young children.3 Mild anemia is also
a common finding.
Diagnosis of EPP is based on elevated plasma,
erythrocyte, or fecal concentrations of protopor-
phyrins with normal urinary porphyrins due to
poor water solubility.8A liver biopsy specimen may
reveal an accumulation of deposits with peripor-
tal fibrosis.5 Molecular analysis of the fer-
rochelatase mutation reveals missense, deletion,
and nonsense mutations, leading to functional
deficiency of ferrochelatase.8 The gene has been
mapped to chromosome 18q22.2
Treatment includes avoidance of sunlight and
the use of topical sunscreen agents with an SPF
of > 30 and ideally containing reflective compo-
nents such as zinc or titanium oxide.3Oral admin-
istration of beta carotene has been used as well,
at a dose of 120 to 180 mg daily to achieve a
serum beta carotene level of 600 to 800 mg/dL.8
Beneficial effects are usually seen 1 to 3 months
after the initiation of therapy.8The mechanism of
action may be from the reducing of activated free
oxygen radicals.2Cholestyramine (5 g, three times
daily) has also been used to decrease porphyrin lev-
els.5 Vitamin E and pyridoxine have also been
used, with limited success.3,5 Transfusions of red
blood cells and intravenous heme have been help-
ful in refractory cases.3,5At this time, ferrochelatase
replacement is unavailable.2The prognosis in gen-
eral is good for most patients with EPP in the
absence of liver failure.3
Conclusion
Although erythropoietic protoporphyria is rare
disorder, it may initially present in patients in the
pediatric age group. It may be important for aller-
gists to recognize this entity at an early stage,
especially in patients with cutaneous disorders 
of unclear etiology, to prevent possible life-
threatening complications.
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